Cintas (CTAS) PT Lowered to $220 at Baird
Tweet
Share
E-mailGet Alerts CTAS Hot Sheet
Price: $203.52 +0.22%
Rating Summary:
13 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
13 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Baird analyst Andrew Wittmann lowered the price target on Cintas (NASDAQ: CTAS) to $220.00 (from $230.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- NetEase.com (NTES) PT Lowered to $143 at Macquarie
- Nutanix (NTNX) PT Raised to $80 at Oppenheimer Into EPS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
